Paper20135338
Higher pretherapy and significant decrease during the first 12 months of therapy in serum laminin levels may associate with hepatitis B e antigen seroconversion in chronic hepatitis B patients treated with lamivudine.
Han Q and 7 others. Clin Exp Med, 2010. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Higher pretherapy and significant decrease during the first 12 months of therapy in serum laminin levels may associate with hepatitis B e antigen seroconversion in chronic hepatitis B patients treated with lamivudine. Papers, record 20135338. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20135338
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Higher pretherapy and significant decrease during the first 12 months of therapy in serum laminin levels may associate with hepatitis B e antigen seroconversion in chronic hepatitis B patients treated with lamivudine.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Hepatitis B e Antigens | Major topic |
| Hepatitis B, Chronic | Major topic |
| Laminin | Major topic |
| Lamivudine | Major topic |
| Serum | Major topic |
| Adult | |
| Biomarkers | |
| Female | |
| Humans | |
| Male | |
| Prognosis |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6376944 | The hepatic extracellular matrix. I. Electron immunohistochemical studies in normal rat liver. | Lab Invest | 1984 | https://conductscience.org/library/papers/6376944 | PubMed |
| 2 | 18240869 | Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease. | Antivir Ther | 2007 | https://conductscience.org/library/papers/18240869 | PubMed |
| 3 | 14697813 | Viral hepatitis B. | Lancet | 2003 | https://conductscience.org/library/papers/14697813 | PubMed |
| 4 | 9654535 | A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. | N Engl J Med | 1998 | https://conductscience.org/library/papers/9654535 | PubMed |
| 5 | 15740489 | Factors associated with response to lamivudine: Retrospective study in a tertiary care clinic serving patients with chronic hepatitis B. | J Gastroenterol Hepatol | 2005 | https://conductscience.org/library/papers/15740489 | PubMed |
| 6 | 15470215 | Lamivudine for patients with chronic hepatitis B and advanced liver disease. | N Engl J Med | 2004 | https://conductscience.org/library/papers/15470215 | PubMed |
| 7 | 2505755 | Uptake and degradation in vivo and in vitro of laminin and nidogen by rat liver cells. | Biochem J | 1989 | https://conductscience.org/library/papers/2505755 | PubMed |
| 8 | 10716688 | Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial. | Gut | 2000 | https://conductscience.org/library/papers/10716688 | PubMed |
| 9 | 2693303 | Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis. | Hepatogastroenterology | 1989 | https://conductscience.org/library/papers/2693303 | PubMed |
| 10 | 9696505 | Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy. | J Hepatol | 1998 | https://conductscience.org/library/papers/9696505 | PubMed |
| 11 | 8751212 | The predictive value of serum laminin for the risk of variceal bleeding related to portal pressure levels. | Hepatogastroenterology | 1995 | https://conductscience.org/library/papers/8751212 | PubMed |
| 12 | 3802532 | Serum concentrations of laminin and aminoterminal propeptide of type III procollagen in relation to the portal venous pressure of fibrotic liver diseases. | Clin Chim Acta | 1986 | https://conductscience.org/library/papers/3802532 | PubMed |
| 13 | 9721586 | Wide distribution of laminin-5 gamma 2 chain in basement membranes of various human tissues. | Horm Res | 1998 | https://conductscience.org/library/papers/9721586 | PubMed |
| 14 | 1692550 | Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake. | Gastroenterology | 1990 | https://conductscience.org/library/papers/1692550 | PubMed |
| 15 | 7635514 | Tumour necrosis factor-alpha interacts with laminin and functions as a pro-adhesive cytokine. | Immunology | 1995 | https://conductscience.org/library/papers/7635514 | PubMed |
| 16 | 2707736 | Serum type III procollagen peptide and laminin (Lam-P1) detect alcoholic hepatitis in chronic alcohol abusers. | Hepatology | 1989 | https://conductscience.org/library/papers/2707736 | PubMed |
| 17 | 3894794 | The hepatic extracellular matrix. II. Electron immunohistochemical studies in rats with CCl4-induced cirrhosis. | Lab Invest | 1985 | https://conductscience.org/library/papers/3894794 | PubMed |
| 18 | 9727065 | Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. | J Clin Invest | 1998 | https://conductscience.org/library/papers/9727065 | PubMed |
| 19 | 9658370 | Predictive value of aminotransferase and hepatitis B virus DNA levels on response to interferon therapy for chronic hepatitis B. | J Viral Hepat | 1998 | https://conductscience.org/library/papers/9658370 | PubMed |
| 20 | 10066373 | Laminin 5 promotes activation and apoptosis of the T cells expressing alpha3beta1 integrin. | Exp Cell Res | 1999 | https://conductscience.org/library/papers/10066373 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 30405859 | A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels. | Dis Markers | 2018 | https://conductscience.org/library/papers/30405859 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20135338
GET https://conductscience.org/api/papers/v1/20135338/references?page=2